Show simple item record

dc.contributor.authorBaleeiro, RBen_US
dc.contributor.authorDunmall, LSCen_US
dc.contributor.authorLiu, Pen_US
dc.contributor.authorLu, Sen_US
dc.contributor.authorLone, Yen_US
dc.contributor.authorLemoine, NRen_US
dc.contributor.authorWang, Yen_US
dc.date.accessioned2024-01-09T15:59:34Z
dc.date.available2022-04-28en_US
dc.date.issued2022en_US
dc.identifier.issn1664-3224en_US
dc.identifier.otherARTN 902709
dc.identifier.otherARTN 902709
dc.identifier.otherARTN 902709en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/93684
dc.relation.ispartofFRONTIERS IN IMMUNOLOGYen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectRASen_US
dc.subjectneo-antigensen_US
dc.subjectcancer immunotherapyen_US
dc.subjectcancer vaccineen_US
dc.subjectcancer peptidesen_US
dc.subjectT-cellsen_US
dc.titleOptimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapyen_US
dc.typeArticle
dc.identifier.doi10.3389/fimmu.2022.902709en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000812763700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume13en_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States